Christopher Jackson

6.5k total citations · 1 hit paper
72 papers, 1.6k citations indexed

About

Christopher Jackson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Christopher Jackson has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Christopher Jackson's work include Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (10 papers) and Global Cancer Incidence and Screening (9 papers). Christopher Jackson is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (10 papers) and Global Cancer Incidence and Screening (9 papers). Christopher Jackson collaborates with scholars based in New Zealand, United States and United Kingdom. Christopher Jackson's co-authors include Diana Sarfati, Bogda Koczwara, David Cunningham, Júlio Oliveira, H. James Williams, Daniel O. Clegg, Valerie Lewington, Gina Brown, Bhupinder Sharma and Gary Cook and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Christopher Jackson

70 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The impact of comorbidity on cancer and its treatment

2016 480 citations Christopher Jackson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Jackson New Zealand	18	590	254	223	190	175	72	1.6k
Lauren P. Wallner United States	28	656 1.1×	254 1.0×	430 1.9×	268 1.4×	229 1.3×	130	2.0k
Emma Simpson United Kingdom	19	200 0.3×	189 0.7×	162 0.7×	244 1.3×	221 1.3×	47	1.6k
Beth Barber United States	24	712 1.2×	88 0.3×	418 1.9×	322 1.7×	138 0.8×	83	2.1k
Nicholas Latimer United Kingdom	29	510 0.9×	207 0.8×	319 1.4×	258 1.4×	298 1.7×	107	2.7k
Ahmet Alacacıoğlu Türkiye	25	948 1.6×	143 0.6×	369 1.7×	254 1.3×	199 1.1×	159	2.0k
Shari Goldfarb United States	26	1.3k 2.2×	120 0.5×	387 1.7×	289 1.5×	176 1.0×	96	3.1k
Jipan Xie United States	24	485 0.8×	96 0.4×	370 1.7×	194 1.0×	304 1.7×	133	2.4k
K. Sundquist United States	22	484 0.8×	117 0.5×	575 2.6×	171 0.9×	223 1.3×	45	1.9k
Christopher V. Almario United States	25	426 0.7×	184 0.7×	223 1.0×	679 3.6×	266 1.5×	99	2.2k
Hossein Neámatzadeh Iran	24	474 0.8×	207 0.8×	210 0.9×	370 1.9×	182 1.0×	194	2.1k

Countries citing papers authored by Christopher Jackson

Since Specialization

Citations

This map shows the geographic impact of Christopher Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Jackson more than expected).

Fields of papers citing papers by Christopher Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Jackson. The network helps show where Christopher Jackson may publish in the future.

Co-authorship network of co-authors of Christopher Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Jackson. A scholar is included among the top collaborators of Christopher Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Jackson. Christopher Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gurney, Jason, James Stanley, Alex Dunn, et al.. (2025). National variation in the treatment of lung cancer in a universal healthcare context. British Journal of Cancer. 133(3). 346–352. 1 indexed citations

Teng, Andrea, James Stanley, Jeremy Krebs, et al.. (2025). Projected increases in the prevalence of diabetes mellitus in Aotearoa New Zealand, 2020–2044. New Zealand Medical Journal. 138(1608). 94–106. 1 indexed citations

Jackson, Christopher, et al.. (2025). Impact of the surgical workflow and technology change on early clinical outcomes in total knee arthroplasty. Journal of Orthopaedics. 71. 32–39.

Medlicott, Natalie J., Yi Wang, Noelyn Hung, et al.. (2024). A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study. Pharmaceutics. 16(5). 602–602. 1 indexed citations

Gurney, Jason, James Stanley, Paul Dawkins, et al.. (2024). Access to and Timeliness of Lung Cancer Surgery, Radiation Therapy, and Systemic Therapy in New Zealand: A Universal Health Care Context. JCO Global Oncology. 10(10). e2300258–e2300258. 4 indexed citations

Teng, Andrea, James Stanley, Christopher Jackson, et al.. (2024). The growing cancer burden: Age-period-cohort projections in Aotearoa New Zealand 2020-2044. Cancer Epidemiology. 89. 102535–102535. 2 indexed citations

Day, Daphne, Val Gebski, John Simes, et al.. (2023). 586P Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial. Annals of Oncology. 34. S426–S427. 1 indexed citations

Jackson, Christopher, et al.. (2022). The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis. PLoS ONE. 17(12). e0275321–e0275321. 15 indexed citations

Jackson, Christopher, et al.. (2022). Did new treatments contribute to a decrease in melanoma deaths?. New Zealand Medical Journal. 135(1558). 90–95. 1 indexed citations

10.

Jackson, Christopher, Eva Segelov, Hans Prenen, et al.. (2021). Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study. British Journal of Clinical Pharmacology. 87(12). 4670–4680. 11 indexed citations

11.

Aldred, Rachel, Rob Johnson, Christopher Jackson, & James Woodcock. (2020). How does mode of travel affect risks posed to other road users? An analysis of English road fatality data, incorporating gender and road type. Injury Prevention. 27(1). 71–76. 18 indexed citations

12.

Young, Jessica, et al.. (2018). The euthanasia debate: synthesising the evidence on New Zealander's attitudes. Kōtuitui New Zealand Journal of Social Sciences Online. 14(1). 1–21. 21 indexed citations

13.

Jackson, Christopher, et al.. (2017). Risk Factors for Adverse Outcome for Elderly Patients undergoing Curative Oncological Resection for Gastrointestinal Malignancies. Visceral Medicine. 33(4). 254–261. 2 indexed citations

14.

Jackson, Christopher, et al.. (2017). Overlapping Risky Decision-Making and Olfactory Processing Ability in HIV-Infected Individuals. PubMed. 3(3). 2 indexed citations

15.

Johnson, Judith, Christopher A. Jones, Ashleigh Lin, et al.. (2014). Shame amplifies the association between stressful life events and paranoia amongst young adults using mental health services: Implications for understanding risk and psychological resilience. Psychiatry Research. 220(1-2). 217–225. 25 indexed citations

16.

Simpson, Andrew, et al.. (2013). A workforce survey of New Zealand medical oncologists.. PubMed. 126(1371). 45–53. 11 indexed citations

17.

Jackson, Christopher & David Cunningham. (2008). Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer. European Journal of Cancer. 44(5). 652–662. 2 indexed citations

18.

Kong, Grace, Christopher Jackson, Dow‐Mu Koh, et al.. (2008). The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. European Journal of Nuclear Medicine and Molecular Imaging. 35(7). 1323–1329. 93 indexed citations

19.

Jackson, Christopher. (2001). Immunomodulating Drugs in the Management of Psoriatic Arthritis. American Journal of Clinical Dermatology. 2(6). 367–375. 4 indexed citations

20.

Olsen, Nancy J., Raye H. Brooks, John J. Cush, et al.. (1996). A double‐blind, placebo‐controlled study of anti‐CD5 immunoconjugate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 39(7). 1102–1108. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact